Home > Pressrelease > HLA Typing for Transplant Market size to exceed $1.7Bn by 2032

HLA Typing for Transplant Market size to exceed $1.7Bn by 2032

  • Published Date: November 23, 2022

HLA Typing for Transplant Market size is anticipated to reach over USD 1.7 billion by 2032, as per a recent research report announced by Global Market Insights Inc.

Rising geriatric patient pool suffering from chronic diseases will complement the HLA typing for transplant industry outlook. Organ failure due to chronic diseases is a major concern among the elderly population. With technological advancements, the success rate of organ transplant surgeries has increased considerably in recent years. An increase in liver and kidney transplant procedures should drive the need for HLA typing.

Need for affordable diagnosis and treatment to boost the demand for non-molecular assays

HLA typing for transplant market share from non-molecular assays technology surpassed USD 115 million in 2022. Non-molecular assays help identify the molecules responsible for immune rejection of the incompatible grafts along with molecules expressed on the cell. It includes lymphocyte culture and serological assays. Serological tests are considered to be a better alternative to regular PCR-based testing as they are easier to perform and less expensive. Additionally, non-molecular tests have low specificity and high sensitivity enabling accurate detection.

Browse key industry insights spread across 255 pages with 354 market data tables & 19 figures & charts from the report, “HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), By Product And Services (Instruments, Reagents And Consumables, Software, Services), By Application (Diagnostics, Research), By End-Use (Hospitals, Diagnostic Labs, Academic And Research Institutes), Industry Analysis Report, Industry Analysis Report, Regional Outlook Growth Potential, Competitive Market Share & Forecast, 2023-2032” in detail along with the table of contents:

Advancements in customized HLA typing & crossmatching services

HLA typing for transplant market from services is projected to witness over 7.5% CAGR between 2023-2032. HLA typing services encompass a wide range of offerings for diagnostics, registry typing, confirmatory typing, and validation & submission of the new allele. HLA antibody screening and lymphocyte crossmatching services improve the survival rate of patients that have undergone transplantation and the rate of complete remission. Large organizations and laboratories offer services tailored to the needs of their clients. While healthcare facilities provide a suite of services to ensure compatible organ transplant surgeries are performed and other consequences are avoided.

Robust investments and funding to accelerate R&D for enhanced HLA typing tests for transplants

HLA typing for transplant market from research application is anticipated to exhibit over 8.5% CAGR from 2023-2032. Extensive research and development (R&D) efforts are made to focus on the introduction of next-generation HLA typing tests pertaining to organ transplantation. Researchers have taken a statistical approach that uses superior-quality HLA data to minimize the ambiguity associated with poor-quality data sets. A large number of private and public organizations are investing in the advancement and innovation of HLA typing tests.

Surge in stem cell transplants to augment Europe HLA typing for transplant industry

Europe HLA typing for transplant market is expected to exceed USD 575 million by 2032. The rising number of organ and stem cell transplant surgeries across the region will be a pivotal factor augmenting industry growth. According to the Global Observatory on Donation & Transplantation report, in 2020, approximately 36,181 organ transplants were performed in Europe and over 150,000 patients were registered on organ waiting list. The region is also expected to witness high stem cell transplant activitywhich should accelerate the need for HLA typing tests.

New product innovations to boost HLA typing for transplant industry expansion

Abbott Laboratories, Bio-Rad Laboratories, CareDx, Luminex Corporation, BioReference Laboratories, GenDx, Illumina Inc., Immucor Inc., Inno-train Diagnostik GmbH, Omixon, Inc., Pacific Biosciences of California, Inc, Qiagen N.V., F. Hoffmann-La Roche Ltd, Thermo-Fisher Scientific Inc., Fujirebio, BAG Diagnostic GmbH, GMSbiotech, Inc., Biofortuna Limited, TBG Diagnostics Limited are some of the leading companies in the global HLA typing for transplant industry.

Authors: Sumant Ugalmugle, Rupali Swain